Paul Sean Little Eledon Pharmaceuticals, Inc. (ELDN) insider trading activity
Paul Sean Little is Chief Financial Officer of Eledon Pharmaceuticals, Inc.. Currently has a direct ownership of 10,000 shares of ELDN, which is worth approximately $43,000. The most recent transaction as insider was on Jun 11, 2021, when has been sold 10,000 shares (Common Stock) at a price of $8.87 per share, resulting in proceeds of $88,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
0%
3M change
0%
12M change
Total Value Held
$43,000
Paul Sean Little Transaction History
Also insider at
PSL
Paul Sean Little
Chief Financial Officer
Santa Barbara, CA